EFHC1
EF-hand domain-containing protein 1
Also known as: EFHC1_HUMAN, EJM, EJM1, FLJ10466, POC9, RIB72
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JVL4
- Gene
- EFHC1
- Ensembl
- ENSG00000096093
- Chromosome
- 6
- Canonical length
- 640 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol,Equatorial segment,Mid piece,Principal piece,End piece
OverviewNCBI Gene
This gene encodes an EF-hand-containing calcium binding protein. The encoded protein likely plays a role in calcium homeostasis. Mutations in this gene have been associated with susceptibility to juvenile myoclonic epilepsy and juvenile absence epilepsy. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
Canonical amino-acid sequenceUniProt
640 residues, UniProt reviewed canonical sequence.
>Q5JVL4|EFHC1
1 MVSNPVHGLP FLPGTSFKDS TKTAFHRSQT LSYRNGYAIV RRPTVGIGGD RLQFNQLSQA
61 ELDELASKAP VLTYGQPKQA PPADFIPAHV AFDKKVLKFD AYFQEDVPMS TEEQYRIRQV
121 NIYYYLEDDS MSVIEPVVEN SGILQGKLIK RQRLAKNDRG DHYHWKDLNR GINITIYGKT
181 FRVVDCDQFT QVFLESQGIE LNPPEKMALD PYTELRKQPL RKYVTPSDFD QLKQFLTFDK
241 QVLRFYAIWD DTDSMYGECR TYIIHYYLMD DTVEIREVHE RNDGRDPFPL LMNRQRVPKV
301 LVENAKNFPQ CVLEISDQEV LEWYTAKDFI VGKSLTILGR TFFIYDCDPF TRRYYKEKFG
361 ITDLPRIDVS KREPPPVKQE LPPYNGFGLV EDSAQNCFAL IPKAPKKDVI KMLVNDNKVL
421 RYLAVLESPI PEDKDRRFVF SYFLATDMIS IFEPPVRNSG IIGGKYLGRT KVVKPYSTVD
481 NPVYYGPSDF FIGAVIEVFG HRFIILDTDE YVLKYMESNA AQYSPEALAS IQNHVRKREA
541 PAPEAESKQT EKDPGVQELE ALIDTIQKQL KDHSCKDNIR EAFQIYDKEA SGYVDRDMFF
601 KICESLNVPV DDSLVKELIR MCSHGEGKIN YYNFVRAFSNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EFHC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 33 nTPM
- choroid plexus: 25 nTPM
- retina: 20 nTPM
- testis: 16 nTPM
- pituitary gland: 15 nTPM
- thyroid gland: 9 nTPM
Single-cell type
- respiratory ciliated cells: 664 nCPM
- fallopian tube ciliated cells: 483 nCPM
- epididymal efferent duct ciliated cells: 481 nCPM
- ependymal cells: 457 nCPM
- endometrial ciliated cells: 432 nCPM
- choroid plexus epithelial cells: 352 nCPM
Immune cell
- plasmacytoid DC: 6.2 nTPM
- naive B-cell: 4 nTPM
- memory B-cell: 3.9 nTPM
- neutrophil: 2 nTPM
- eosinophil: 1.5 nTPM
- NK-cell: 1.5 nTPM
Brain region
- choroid plexus: 57 nTPM
- medulla oblongata: 24 nTPM
- midbrain: 24 nTPM
- basal ganglia: 19 nTPM
- white matter: 19 nTPM
- spinal cord: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EFHC1.
Disease | AllUniProt
Conditions EFHC1 is implicated in, by any mechanism.
- Juvenile myoclonic epilepsy 1 (EJM1) MIM:254770
- Juvenile absence epilepsy 1 (JAE1) MIM:607631
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.14
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cerebral cortex cell migration
- cilium-dependent cell motility
- flagellated sperm motility
- mitotic cytokinesis
- mitotic spindle organization
- regulation of cell division
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EFHC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EFHC1 as an antibody target. Whether an autoantibody or antibody against EFHC1 could matter depends on whether native EFHC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EFHC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EFHC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...